CityU developed the AI and EEG based drug’s screening platform to facilitate the drug-screening process of investigational new drugs, predict the potential activity, pharmacological targets and toxicity. It helps to identify the most promising compounds with efficient manner, resulting in saving of cost and time and accelerate the drug development process.
The process of developing a novel drug is time consuming and costly. Merely a small fraction of investigational new drugs tested in clinical trials after passing preclinical evaluation eventually lead to a marketed product. Hence, Our AI platform offer an opportunity to overcome these obstacles and enhance the success rate of drug development to enter in the market.
As one of the fastest growing universities in the world over the past decade, City University of Hong Kong (CityU) is recognised as a hub for innovation in research and professional education. CityU identifies solutions to critical global challenges by extending the frontiers of knowledge both within and beyond existing research paradigms.
The University’s highly qualified academics are drawn from all over the world, not only bringing a wealth of research and professional experience to the teaching programmes, but also contributing to the knowledge and technology advancement.